CMS Defends Access To Medicare Rx Pricing Data: Dialogue, Not Interference
Executive Summary
The Centers for Medicare & Medicaid Services' ability to review drug pricing data in evaluating plan bids for Medicare does not constitute "interference" in price negotiations as defined in the Medicare Modernization Act, the agency said